Skip to content

Drug interactions

Capmatinib + Ribociclib

Severity: Moderate

Capmatinib and Ribociclib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Capmatinib is a CYP3A4 substrate and ribociclib may increase its levels. This may increase adverse effects such as edema, nausea and hepatotoxicity.

What this interaction means in plain words

Capmatinib and Ribociclib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Capmatinib belongs to Oncology; Ribociclib belongs to Oncology.

Evidence level: Low

Why it happens

Ribociclib inhibits CYP3A4, lowering capmatinib clearance.

What to do

Monitor liver tests and adverse effects, and reduce the capmatinib dose if toxicity occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Capmatinib and Ribociclib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Capmatinib with Ribociclib?

MediHelp rates the interaction as moderate. Capmatinib and Ribociclib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Capmatinib is a CYP3A4 substrate and ribociclib may increase its levels. This may increase adverse effects such as edema, nausea and hepatotoxicity.

How serious is the interaction between Capmatinib and Ribociclib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver tests and adverse effects, and reduce the capmatinib dose if toxicity occurs.

What other medicines interact with Ribociclib?

MediHelp also lists interactions of Ribociclib with, for example, Amiodarone, Cisapride, Dofetilide. The full list is on the Ribociclib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in